Dermot Kelleher
Director/Board Member at Cellix Ltd.
Profile
Dermot P.
Kelleher is the founder of Opsona Therapeutics Ltd.
founded in 2004.
Currently, he is a Director at Cellix Ltd., The Institute of Molecular Medicine, and Dean at the University of British Columbia.
Previously, he served as an Independent Non-Executive Director at ICON plc from 2008 to 2019, Head of Medicine School at Trinity College Dublin from 2004 to 2012, Dean at Lee Kong Chian School of Medicine from 2012 to 2014, Principal-Faculty of Medicine at Imperial College London in 2015, and President at Federation of European Academies of Medicine.
Dermot Kelleher active positions
Companies | Position | Start |
---|---|---|
Cellix Ltd.
Cellix Ltd. Medical SpecialtiesHealth Technology Cellix Ltd. develops microfluidic pumping solutions, consumable biochips, software, and automated solutions. It offers its solutions for applications in cell biology, microfluidics and nanofluidics, physics, chemistry, cell, and particle studies. The company was founded by Dmitry Kashanin, Vivienne Williams, Francis Odowd, and Igor Shvets in 2004 and is headquartered in Dublin, Ireland. | Director/Board Member | - |
The Institute of Molecular Medicine | Director/Board Member | 2009-09-23 |
University of British Columbia | Corporate Officer/Principal | - |
Former positions of Dermot Kelleher
Companies | Position | End |
---|---|---|
ICON PUBLIC LIMITED COMPANY | Director/Board Member | 2019-07-24 |
Lee Kong Chian School of Medicine | Corporate Officer/Principal | 2013-12-31 |
Trinity College Dublin | Corporate Officer/Principal | 2011-12-31 |
Federation of European Academies of Medicine | President | - |
Imperial College London | Corporate Officer/Principal | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
ICON PUBLIC LIMITED COMPANY | Commercial Services |
Private companies | 4 |
---|---|
Cellix Ltd.
Cellix Ltd. Medical SpecialtiesHealth Technology Cellix Ltd. develops microfluidic pumping solutions, consumable biochips, software, and automated solutions. It offers its solutions for applications in cell biology, microfluidics and nanofluidics, physics, chemistry, cell, and particle studies. The company was founded by Dmitry Kashanin, Vivienne Williams, Francis Odowd, and Igor Shvets in 2004 and is headquartered in Dublin, Ireland. | Health Technology |
Opsona Therapeutics Ltd.
Opsona Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Opsona Therapeutics Ltd. operates as a immunology drug development company. It focuses on novel therapeutics and specializes in the prevention and treatment of solid organ transplantation, cancer, diabetes, autoimmune, inflammatory and Alzheimer’s diseases. The firm developed OPN-305, an antibody to reduce pro-inflammatory cytokine production, which is now at the clinical testing phase. The company was founded by Luke O'Neill, Kingston Mills and Dermot Kelleher in 2004 and is headquartered Dublin, Ireland. | Health Technology |
The Institute of Molecular Medicine | |
Federation of European Academies of Medicine |
- Stock Market
- Insiders
- Dermot Kelleher